A comprehensive view of regeneron pharmaceuticals inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Regeneron Pharmaceuticals on Jan. 24 for "Fucosylation-deficient cells" (New York Inventors)
Published: January 25, 2023 by U.S. Fed News
US Patent Issued to REGENERON PHARMACEUTICALS on Jan. 24 for "Use of a VEGF antagonist to treat angiogenic eye disorders" (New York Inventor)
Published: January 25, 2023 by U.S. Fed News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "PROTEIN N-TERMINAL DE NOVO SEQUENCING BY POSITION-SELECTIVE DIMETHYLATION"
Published: January 25, 2023 by U.S. Fed News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "MASS SPECTROMETRY-BASED STRATEGY FOR DETERMINING PRODUCT-RELATED VARIANTS OF A BIOLOGIC"
Published: January 25, 2023 by U.S. Fed News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-SARS-COV-2-SPIKE GLYCOPROTEIN ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS"
Published: January 25, 2023 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count